α
AlphaScala
StocksSignalsNEWAlpha ScoreBriefingsNEWBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsMarket BriefingsAlpha ScoreHedge Funds 13FInsider BuysPolitician TradesAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutMethodologyEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala – Built with data, not hype.
All Stocks/Healthcare/LMAT

LEMAITRE VASCULAR INC

LMAT
HealthcareMedical Instruments & Supplies Website
Signal SnapshotMarket signals →
Alpha Score
Score pending
Alpha Score appears once the required price and fundamentals data has ingested.
Daily model
Insiders
No recent signal
No recent open-market insider buying or selling is in the current rollup.
Form 4
13F Holder
Renaissance Technologies
$14.64M reported position; latest action: new.
Jim Simons (founder)
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about LMATAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Renaissance Technologies
Jim Simons (founder)
181K$14.64MNEW
Marshall Wace48K$3.91MNEW
D.E. Shaw
David Shaw
43K$3.47MNEW
Citadel
Ken Griffin
18K$1.44MNEW
Explore all tracked funds →
About LEMAITRE VASCULAR INC

LeMaitre Vascular Inc. develops, manufactures, and markets specialized medical devices and implants designed for vascular surgery and the treatment of peripheral vascular disease. The company offers a comprehensive portfolio of products across six key categories: aortic, arteriovenous access, cardiac, carotid, lower extremity, and neuro applications. Its product lines include allografts—cryopreserved human tissue grafts used in vascular reconstruction—embolectomy catheters for removing blood clots from arteries, thrombectomy catheters for venous thrombi removal, and various synthetic and biologic grafts and patches. LeMaitre also provides human tissue cryopreservation services. The company distributes its products globally through direct sales to hospitals in over 25 countries and through distributors in more than 70 countries across North America, Europe, and Asia-Pacific. Founded in 1986 and headquartered in Burlington, Massachusetts, LeMaitre serves vascular surgeons performing both open surgical procedures and minimally invasive interventions, with the majority of its revenue generated from the United States market.

CEO
Mr. George W. LeMaitre
Employees
646
Quick Facts
Exchange–
SectorHealthcare
IndustryMedical Instruments & Supplies
Market Cap–
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when LMAT reports next.

Get earnings alerts →